China Resources Pharma to review interim results, weigh dividend at board meetingPUBT·Aug 11 at 05:07 PM03320+1.24%
China Resources Pharmaceutical Moves to Become Largest Shareholder in Lier ChemicalTip Ranks·Jul 29 at 05:37 PM002258+0.60%03320+1.24%
China Resources Pharma unit CR Pharmaceutical Holdings issues RMB 1 billion 3-year notes at 1.52% couponPUBT·Jul 29 at 05:39 AM03320+1.24%
China Resources Pharma unit tops bid to buy 23.5% stake in Lier ChemicalPUBT·Jul 15 at 09:12 AM002258+0.60%600062-0.44%
Tasly Delivers Profit Growth on Flat Revenue, Bolstering China Resources PharmaceuticalTip Ranks·Jul 14 at 07:08 AM03320+1.24%600535+0.52%
China Resources Pharmaceutical files board, committee and disclosure-responsible management listPUBT·Jul 13 at 03:34 AM03320+1.24%
China Resources Pharmaceutical appoints Zhang Jing as non-executive directorPUBT·Jul 13 at 03:34 AM03320+1.24%
China Resources Pharmaceutical declares 2025 final dividend of RMB 0.122 a sharePUBT·Jun 29 at 05:09 PM03320+1.24%
China Resources Pharmaceutical Raises RMB2 Billion in Third Tranche of 2026 PRC BondsTip Ranks·Jun 26 at 07:18 AM03320+1.24%
23:56 ETChina Resources Group Participates in the 4th CISCE, Unveils "China Resources Low-Carbon Eco-Community"prnewswire·Jun 22 at 10:57 PM03320+1.24%00836-1.15%
CHINARES PHARMAs Innovative Drug BGM0504 for Weight Loss Has NDA AcceptedAASTOCKS News·Jun 15 at 04:40 AM03320+1.24%
China Resources Pharmaceutical Wins Shareholder Backing for Dividend, Board and Capital MandatesTip Ranks·Jun 12 at 07:41 AM03320+1.24%
China Resources Pharmaceutical Completes RMB1.4 Billion Second Tranche of 2026 Bonds in ChinaTip Ranks·Apr 28 at 04:38 AM03320+1.24%
